{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:57:32Z","timestamp":1791176252750,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ijpharm.2011.08.016","type":"journal-article","created":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T19:18:46Z","timestamp":1313522326000},"page":"122-132","source":"Crossref","is-referenced-by-count":56,"title":["PLGA nanoparticles loaded with the antileishmanial saponin \u03b2-aescin: Factor influence study and in vitro efficacy evaluation"],"prefix":"10.1016","volume":"420","author":[{"given":"H.","family":"Van de Ven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vermeersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Matheeussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Vandervoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Weyenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Apers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2011.08.016_bib0005","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","article-title":"Freeze-drying of nanoparticles: formulation, process and storage considerations","volume":"58","author":"Abdelwahed","year":"2006","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.chroma.2005.10.069","article-title":"Densitometric thin-layer chromatographic determination of aescin in a herbal medicinal product containing Aesculus and Vitis dry extracts","volume":"1112","author":"Apers","year":"2006","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0006-3495(99)77196-1","article-title":"The membrane-permeabilizing effect of avenacin A-1 involves the reorganization of bilayer cholesterol","volume":"76","author":"Armah","year":"1999","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0020","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.addr.2007.06.008","article-title":"Endocytic mechanisms for targeted drug delivery","volume":"59","author":"Bareford","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0025","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1006\/jcis.1995.1047","article-title":"Dynamic properties of poly(dl-lactide) and polyvinyl alcohol monolayers at the air\/water and dichloromethane\/water interfaces","volume":"169","author":"Boury","year":"1995","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejpb.2007.06.010","article-title":"Polymers and nanoparticles: intelligent tools for intracellular targeting","volume":"68","author":"Breunig","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0035","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jconrel.2007.10.027","article-title":"Delivery systems to increase the selectivity of antibiotics in phagocytic cells","volume":"125","author":"Briones","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0040","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0045","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1016\/j.biomaterials.2005.05.044","article-title":"Therapeutic potential of nanoparticulate systems for macrophage targeting","volume":"26","author":"Chellat","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5173(00)00574-3","article-title":"Effects of the rate of solvent evaporation on the characteristics of drug loaded PLLA and PDLLA microspheres","volume":"212","author":"Chung","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0055","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jep.2006.04.003","article-title":"Demonstration of anti-infective potential of natural products \u2013 how to develop a stronger in vitro \u2018proof-of-concept\u2019","volume":"106","author":"Cos","year":"2006","journal-title":"J. Ethnopharmacol."},{"issue":"Suppl","key":"10.1016\/j.ijpharm.2011.08.016_bib0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1359-6446(01)00151-9","article-title":"High-throughput cytotoxicity screening: hit and miss","volume":"6","author":"Crouch","year":"2001","journal-title":"Drug Discov. Today"},{"issue":"11","key":"10.1016\/j.ijpharm.2011.08.016_bib0065","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/jps.20301","article-title":"Polysorbate 80 and cremophor EL micelles deaggregate and solubilise nystatin at the core-corona interface","volume":"94","author":"Croy","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0070","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jconrel.2005.07.001","article-title":"Preparation and characterization of melittin-loaded poly (dl-lactic acid) or poly (dl-lactic-co-glycolic acid) microspheres made by the double emulsion method","volume":"107","author":"Cui","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0075","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.addr.2007.04.009","article-title":"Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles","volume":"59","author":"Date","year":"2007","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0080","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-2000-8541","article-title":"Antileishmanial activity of three saponins isolated from ivy, \u03b1-hederin, \u03b2-hederin and hederacolchiside A1, as compared to their action on mammalian cells cultured in vitro","volume":"66","author":"Delmas","year":"2000","journal-title":"Planta Med."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0085","doi-asserted-by":"crossref","first-page":"9504","DOI":"10.1021\/la034999q","article-title":"The design of nanoparticles obtained by solvent evaporation: a comprehensive study","volume":"19","author":"Desgouilles","year":"2003","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0090","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/cbdv.200800070","article-title":"Naturally occurring triterpenoid saponins","volume":"7","author":"Dinda","year":"2010","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0095","unstructured":"DNDi, 2008. 2007\u20132008 Annual report, drugs for neglected diseases initiative, Geneva, Switzerland."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0100","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1099\/jmm.0.47114-0","article-title":"Racemoside A, an anti-leishmanial, water-soluble, natural steroidal saponin, induces programmed cell death in Leishmania donovani","volume":"56","author":"Dutta","year":"2007","journal-title":"J. Med. Microbiol."},{"issue":"3","key":"10.1016\/j.ijpharm.2011.08.016_bib0105","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4103\/0974-777X.68528","article-title":"Human immunodeficiency virus and leishmaniasis","volume":"2","author":"Ezra","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0110","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.bmc.2009.02.043","article-title":"Nanoparticles in cellular drug delivery","volume":"17","author":"Faraji","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0115","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1021\/la971271z","article-title":"Some stability criteria for double emulsions","volume":"14","author":"Ficheux","year":"1998","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jconrel.2004.10.015","article-title":"Microencapsulation by solvent extraction\/evaporation: reviewing the state of the art of microsphere preparation process technology","volume":"102","author":"Freitas","year":"2005","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.ijpharm.2011.08.016_bib0125","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1517\/17425247.2010.529897","article-title":"New delivery strategies for the old pentavalent antimonial drugs","volume":"7","author":"Fr\u00e9zard","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"issue":"8","key":"10.1016\/j.ijpharm.2011.08.016_bib0130","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1023\/B:PHAM.0000036917.75634.be","article-title":"Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods","volume":"21","author":"Galindo-Rodriguez","year":"2004","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ijpharm.2011.08.016_bib0135","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17425240903548232","article-title":"Drug delivery strategies for therapy of visceral leishmaniasis","volume":"7","author":"Gupta","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0140","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejpb.2009.02.002","article-title":"Physico-chemical characterisation of PLGA nanoparticles after freeze-drying and storage","volume":"72","author":"Holzer","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/IJN.S7879","article-title":"Nanoparticulate Quillaja saponin induces apoptosis in human leukemia cell lines with a high therapeutic index","volume":"5","author":"Hu","year":"2010","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.ijpharm.2011.08.016_bib0150","first-page":"1","article-title":"Techniques for efficient entrapment of pharmaceuticals in biodegradable solid micro\/nanoparticles","volume":"7","author":"Ishihara","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0155","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.addr.2009.03.005","article-title":"In vitro assessments of nanomaterial toxicity","volume":"61","author":"Jones","year":"2009","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0160","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/092986709787458489","article-title":"Leishmaniasis: current treatment and prospects for new drugs and vaccines","volume":"16","author":"Kedzierski","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0165","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.biomaterials.2005.04.041","article-title":"Influence of polysaccharide coating on the interactions of nanoparticles with biological systems","volume":"27","author":"Lemarchand","year":"2006","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.ijpharm.2011.08.016_bib0170","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3109\/02652049809006869","article-title":"Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a W\/O\/W solvent evaporation method","volume":"15","author":"Leo","year":"1998","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0175","series-title":"Pharmaceutical Experimental Design","author":"Lewis","year":"1999"},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0180","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2008.07.018","article-title":"Microencapsulation by solvent evaporation: state of the art for process engineering approaches","volume":"363","author":"Li","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2004.11.027","article-title":"PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution","volume":"290","author":"Mainardes","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/617521","article-title":"Drug resistance in visceral leishmaniasis","volume":"2010","author":"Maltezou","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1015559603643","article-title":"An improved resazurin-based cytotoxicity assay for hepatic cells","volume":"18","author":"McMillian","year":"2002","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0200","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0927-7765(99)00088-0","article-title":"Micellar properties of quillaja saponin. 2. Effect of solubilised cholesterol on solution properties","volume":"17","author":"Mitra","year":"2000","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijpharm.2005.12.016","article-title":"PLGA microcapsules with novel dimpled surfaces for pulmonary delivery of DNA","volume":"311","author":"Mohamed","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0378-5173(96)04539-5","article-title":"Cytotoxicity of magnetite-loaded polylactide, polylactide\/glycolide particles and solid lipid nanoparticles","volume":"138","author":"M\u00fcller","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0215","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijpharm.2009.04.049","article-title":"Relevance of the colloidal stability of chitosan\/PLGA nanoparticles on their cytotoxicity profile","volume":"381","author":"Nafee","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0220","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijpharm.2007.08.046","article-title":"Effect of surface properties of liposomes coated with a modified polyvinyl alcohol (PVA-R) on the interaction with macrophage cells","volume":"354","author":"Nakano","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0225","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the Alamar Blue (resaruzin) fluorescent dye for the assessment of mammalian cell cytotoxicity","volume":"267","author":"O\u2019Brien","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nano.2005.12.003","article-title":"Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles","volume":"2","author":"Reis","year":"2006","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0235","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cbpa.2010.03.023","article-title":"New antileishmanial candidates and lead compounds","volume":"14","author":"Richard","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0240","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0939-6411(98)00038-1","article-title":"Surface-modified biodegradable albumin nano-and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats","volume":"46","author":"Roser","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0245","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1006\/jcis.1996.4637","article-title":"The adsorption of poly(vinyl alcohol) to biodegradable microparticles studied by X-ray photoelectron spectroscopy (XPS)","volume":"185","author":"Shakesheff","year":"1997","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0250","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.biomaterials.2008.12.070","article-title":"Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan","volume":"30","author":"Sheng","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0255","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jep.2004.05.016","article-title":"Biological activities and distribution of plant saponins","volume":"94","author":"Sparg","year":"2004","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0260","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jconrel.2004.03.023","article-title":"Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study","volume":"97","author":"Ubrich","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0265","first-page":"172","article-title":"Solid lipid nanoparticle (SLN) formulations as a potential tool for the reduction of cytotoxicity of saponins","volume":"64","author":"Van de Ven","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0270","doi-asserted-by":"crossref","unstructured":"Van de Ven, H., Vermeersch, M., Vandenbroucke, R.E., Matheeussen, A., Apers, S., Weyenberg, W., De Smedt, S.C., Cos, P., Maes, L., Ludwig, A., in press. Intracellular drug delivery in Leishmania-infected macrophages: evaluation of saponin-loaded PLGA nanoparticles. J. Drug Target, doi:10.3109\/1061186X.2011.595491.","DOI":"10.3109\/1061186X.2011.595491"},{"issue":"9","key":"10.1016\/j.ijpharm.2011.08.016_bib0280","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/AAC.00548-09","article-title":"In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences","volume":"53","author":"Vermeersch","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0285","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.addr.2007.11.008","article-title":"Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects","volume":"60","author":"Wong","year":"2008","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymeth.2006.05.016","article-title":"Pathogen recognition and development of particulate vaccines: does size matter","volume":"40","author":"Xiang","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.ijpharm.2011.08.016_bib0295","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ejps.2010.09.006","article-title":"Particle size affects the cellular response in macrophages","volume":"41","author":"Yue","year":"2010","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311007782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311007782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T18:24:50Z","timestamp":1543602290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517311007782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0378517311007782"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2011.08.016","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}